ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Infinity Announces Start of Two IPI-549 Trials for Solid Tumors americanpharmaceuticalreview
September 05, 2019Infinity Pharmaceuticals announced the initiation of two clinical trials for IPI-549, a first-in-class, oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through ...
Pharma Sources Insight January 2025
